The ICRH and CTS established the Distinguished Lecture in Respiratory Sciences Award in 2006 to honour scholars in the respiratory field. Nominations are solicited from the respiratory research community and assessed against the following criteria:

  • impact of the nominee’s research on respiratory sciences in Canada and the extent to which the nominee has contributed significantly to the advancement of respiratory sciences in Canada over the last ten years;
  • relevance/application/impact of nominee’s research to a clinical setting; and
  • demonstrated strength and reputation of the nominee in the field of respiratory sciences in Canada.

It is with great pleasure that CIHR-ICRH and CTS announce that the 2020 Distinguished Lecture in Respiratory Sciences has been awarded to Dr. Don Sin from the University of British Columbia.

Session Description
Although there is a dearth of disease-modifying therapies for COPD currently, the omics technology, coupled with incredible improvements in in vivo phenotyping abilities, is poised to revolutionize the assessment and management of patients with COPD. These tools can accurately characterize patients and enable development of “personalized” treatment of patients. This talk will provide some examples of where COPD treatment has already moved from the “average” patient to the “individual” patient and discuss future strategies to accelerate precision health for millions of Canadians affected by this disease.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Define precision health in COPD;
  • Cite specific examples of “precision health” technologies/treatments in COPD; and
  • Describe the role of biomarkers in enabling precision health.